Traub Capital Management LLC Invests $71,000 in UnitedHealth Group Incorporated $UNH

Traub Capital Management LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 228 shares of the healthcare conglomerate’s stock, valued at approximately $71,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of UNH. Nuveen LLC bought a new stake in shares of UnitedHealth Group in the 1st quarter worth about $3,846,764,000. Vanguard Group Inc. grew its stake in shares of UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after buying an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP boosted its holdings in UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after acquiring an additional 2,486,839 shares during the period. Davis Selected Advisers lifted its position in shares of UnitedHealth Group by 2,234.9% during the second quarter. Davis Selected Advisers now owns 1,132,885 shares of the healthcare conglomerate’s stock worth $353,426,000 after purchasing an additional 1,084,366 shares during the last quarter. Finally, National Bank of Canada FI lifted its holdings in UnitedHealth Group by 137.8% during the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock valued at $859,518,000 after buying an additional 950,928 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 1.4%

Shares of UNH stock opened at $309.19 on Thursday. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $622.83. The stock’s 50-day simple moving average is $346.20 and its 200-day simple moving average is $317.57. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. The firm has a market capitalization of $280.08 billion, a PE ratio of 16.14, a P/E/G ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating the consensus estimate of $2.87 by $0.05. The business had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same period in the prior year, the firm earned $7.15 EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be paid a $2.21 dividend. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on UNH. Sanford C. Bernstein boosted their price target on UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a report on Thursday, October 30th. UBS Group increased their target price on shares of UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a report on Wednesday, October 29th. TD Cowen upped their price target on shares of UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research report on Thursday, October 30th. KeyCorp increased their target price on UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research report on Wednesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 target price on the stock. in a research note on Wednesday, October 29th. Eighteen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $397.12.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.